date:Feb 28, 2014
Oil and bioproducts company Solazyme has announced results for the fourth quarter and full year ended December 31, 2013.
2013 was a year of great progress for Solazyme as we readied our first major capacity projects, signed new commercial supply agreements, added important joint development partners, and further expanded our portfolio of Tailored oils, said Jonathan Wolfson, CEO of Solazyme. In the first half of 2014, we are focused on successfully executing Solazyme's entry into broad commerci